GOLDEN BIOTECHNOLOGY CORP.
Area: Pharmaceutical and Medical Devices
Booth No: R410
Website: http://www.goldenbiotech.com
Exhibitor Profile
Golden Biotechnology Corp.,leading in pharma and supplement products.New drug Antroquinonol(HOCENA) update for Covid-19 coronavirus study and clinical trial in USA. AML,NSCLC, Pancreatic cancer clinical trial achievement. Received Orphan Drug Designations for Pancreatic Cancer, AML and HCC . Released Phase II trial of NSCLC in ASCO meeting. Joined with QUT ,J&J in Alzheimer's Disease study. Successful unblinding on clinical trial of hyperlipid. Visit our booth 4F, R410 or the virtual booth.
Brands
New Drug of Antroquinonol (HOCENA) in Cancers, Covid-19,Alzheimer,Autoimmune
Exhibit Products
Exhibitor Press Release
- CORONAVIRUS/ Antroquinonol, Taiwan’s first to gain FDA approval for Phase 2 trial in COVID-19 2020-07-23
- Seminar:GoldenBiotech's Phase 2 Clinical Trial of Covid-19 Coronavirus in USA & other Cancers trials 2020-07-21
- Gift value NT$1088 for visitor to GoldenBiotech's booth in 2020 Bio Asia Taiwan Exhibition 2020-07-21
Exhibitors you may be interested in
Highest Rated